Published in J Urol on September 01, 2003
Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer (2011) 1.62
Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review. J Clin Oncol (2007) 1.05
Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications. Ann Oncol (2012) 1.04
Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial. BJU Int (2009) 0.95
Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. Br J Cancer (2009) 0.93
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer. Drug Healthc Patient Saf (2011) 0.92
Innovations in the systemic therapy of prostate cancer. Nat Rev Clin Oncol (2009) 0.91
Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer. Nat Rev Clin Oncol (2010) 0.88
Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor. Urol Oncol (2014) 0.84
Treatment options for localized prostate cancer. Can Fam Physician (2013) 0.83
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy. Cancer Gene Ther (2016) 0.82
Preoperative therapy for localized prostate cancer: a comprehensive overview. Maturitas (2012) 0.81
Rationale for and review of neoadjuvant therapy prior to radical prostatectomy for patients with high-risk prostate cancer. Drugs (2013) 0.80
Feasibility of Neoadjuvant Ad-REIC Gene Therapy in Patients with High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy. Clin Transl Sci (2015) 0.79
An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.79
Hormone therapy in the management of prostate cancer: evidence-based approaches. Ther Adv Urol (2010) 0.79
Preoperative androgen deprivation therapy for localized prostate cancer: delayed biochemical recurrence in high-risk disease. Clin Genitourin Cancer (2013) 0.78
Contemporary radical prostatectomy. Prostate Cancer (2011) 0.78
Phase II trial of neoadjuvant docetaxel and CG1940/CG8711 followed by radical prostatectomy in patients with high-risk clinically localized prostate cancer. Oncologist (2013) 0.78
Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients. World J Surg Oncol (2015) 0.77
Downsizing and prostate cancer. Rev Urol (2004) 0.77
Optimal treatment of locally advanced prostate cancer. World J Urol (2007) 0.77
Prostate cancer (early). BMJ Clin Evid (2006) 0.75
The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer. Urol Case Rep (2016) 0.75
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life. Prostate Cancer Prostatic Dis (2009) 0.75
Stromal Androgen Receptor in Prostate Cancer Development and Progression. Cancers (Basel) (2017) 0.75
Radical prostatectomy in locally advanced cancer - an indispensable onset of multimodal therapy? Cent European J Urol (2017) 0.75
Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol (1969) 4.93
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
Detection of blood vessels in retinal images using two-dimensional matched filters. IEEE Trans Med Imaging (1989) 3.76
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA (1977) 3.05
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med (1998) 2.85
AIDS: an international perspective. Science (1988) 2.84
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Herpes simplex encephalitis: a diagnostic and therapeutic reapprisal. J Assoc Physicians India (1993) 2.68
Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet (1978) 2.60
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest (1993) 2.59
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer (1993) 2.56
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48
Prevention of chronic hepatitis B virus infection from mothers to infants in the United States. Pediatrics (1983) 2.41
Malignant breast masses detected only by ultrasound. A retrospective review. Cancer (1995) 2.41
Global surveillance and forecasting of AIDS. Bull World Health Organ (1989) 2.17
Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J Urol (2001) 2.15
The international epidemiology of AIDS. Sci Am (1988) 2.08
Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res (1990) 2.07
Secondary neoplasms of the breast: a survey of the 20th Century. Cancer (2001) 2.07
Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A (1992) 2.06
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 2.02
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol (1998) 1.90
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA (1997) 1.84
Filter paper disc method of collecting whole blood for serologic studies in children. Am J Epidemiol (1966) 1.82
Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J Biol Chem (1994) 1.79
YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci U S A (1992) 1.79
Sequences near the termini are required for transposition of the maize transposon Ac in transgenic tobacco plants. Proc Natl Acad Sci U S A (1989) 1.71
Honey and other environmental risk factors for infant botulism. J Pediatr (1979) 1.68
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med (1988) 1.66
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol (1994) 1.63
Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry (1999) 1.63
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
Country-specific estimates and models of HIV and AIDS: methods and limitations. AIDS (1999) 1.61
Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model. J Steroid Biochem Mol Biol (1996) 1.61
Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol (1995) 1.61
Improved exposure of isolated perimembranous ventricular septal defects. Ann Thorac Surg (2000) 1.59
Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. J Antibiot (Tokyo) (1992) 1.58
Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood (1996) 1.57
Immunocytochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med (1986) 1.57
Unusual type of epidemic conjunctivitis in Ghana. Br J Ophthalmol (1970) 1.56
Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J Clin Microbiol (2010) 1.56
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence. Clin Cancer Res (1999) 1.55
Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol (2000) 1.54
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology (2001) 1.54
Microsurgical trabeculectomy in Ghana. Br J Ophthalmol (1972) 1.53
Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Intern Med J (2004) 1.53
Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol (2006) 1.53
Botulism--diagnosis, management and public health considerations. Calif Med (1973) 1.52
Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A (1988) 1.52
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol (1999) 1.51
Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect (2007) 1.51
Public health implications of rubella antibody levels in California. Am J Public Health (1982) 1.51
Subclinical hypothyroidism: a determinant of polycystic ovary syndrome. Horm Res (1993) 1.49
Quebec prostate cancer mortality dropped in 1996. Cancer Prev Control (1998) 1.49
Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence. J Urol (1998) 1.48
The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med (1995) 1.47
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. Clin Cancer Res (1999) 1.46
Prospective multicenter evaluation of an initially placed button gastrostomy. Gastrointest Endosc (1995) 1.45
Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer (2008) 1.45
Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study. Age Ageing (1989) 1.44
Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis. J Infect Dis (1987) 1.43
Higher urinary potassium is associated with decreased stone growth after shock wave lithotripsy. J Urol (2000) 1.41
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A (1995) 1.41
Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol (2000) 1.41
Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry (1999) 1.40
The new genetics and its application in the study of childhood muscular dystrophies. J Assoc Physicians India (1991) 1.39
Young male with systemic lupus erythematosus presenting with sensorineural deafness with immune suppression induced miliary tuberculosis. J Assoc Physicians India (2011) 1.39
Giant cell tumour of short bones of hand. J Indian Med Assoc (1995) 1.38
Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev (1981) 1.38
Vascular injury and repair associated with retroperitoneal lymphadenectomy for nonseminomatous germinal cell tumours of the testis. Can J Surg (1992) 1.38
Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol (1985) 1.38
Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer (1985) 1.36
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum (2001) 1.36
Prostate cancer: 4. Screening. CMAJ (1998) 1.34
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study. Prostate (2006) 1.33
A novel Campylobacter jejuni two-component regulatory system important for temperature-dependent growth and colonization. J Bacteriol (1999) 1.31
Review of AIDS and HIV infection: global epidemiology and statistics. AIDS (1989) 1.30
Overlapping but distinct RNA elements control repression and activation of nanos translation. Mol Cell (2000) 1.30
Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol (1984) 1.29
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol (2000) 1.29
IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol (1994) 1.28
Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol (2011) 1.25
Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy. Urology (1983) 1.25
Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int (2004) 1.25
Prophylaxis against malaria. BMJ (1995) 1.25
Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J Biol Chem (1996) 1.22